OVERVIEW
Vic Market Research Co., Ltd. is pleased to announce the release of the “Global and Chinese Duchenne Muscular Dystrophy (DMD) Therapeutics Market Insight Report 2025–2031.”
This comprehensive study is designed to provide a structured and in-depth analysis of the Duchenne Muscular Dystrophy (DMD) Therapeutics industry, both domestically and internationally, with a focus on the following key areas:
1.An overview and assessment of the current development status and emerging trends in the Duchenne Muscular Dystrophy (DMD) Therapeutics industry across global and Chinese markets.
2.Estimation of the overall market size of the Duchenne Muscular Dystrophy (DMD) Therapeutics industry, along with a detailed analysis of market share by major countries.
3.Evaluation of the development potential within various segments of the Duchenne Muscular Dystrophy (DMD) Therapeutics industry, analysis of downstream market demand, and an examination of the competitive landscape.
4.Identification and exploration of industry pain points, aiming to support stakeholders in addressing key challenges effectively.
This report integrates extensive desk research with qualitative interviews conducted with industry experts and insiders, ensuring both the objectivity and comprehensiveness of the findings and data.
The study provides a detailed examination of the production, consumption, import, and export dynamics of the Duchenne Muscular Dystrophy (DMD) Therapeutics market in China. It also highlights key global and domestic manufacturers that play a significant role in the Chinese market, presenting core performance indicators such as sales volume, revenue, pricing, gross margin, and market share.
Furthermore, the report delivers a thorough analysis of segmented growth within the Duchenne Muscular Dystrophy (DMD) Therapeutics product category, including differentiation by product types, pricing, sales, revenue, and application-specific market performance. Historical data from 2020 to 2024 is incorporated, with forward-looking projections extending through 2031.
In light of the significant uncertainty introduced by the U.S. tariff policy set to take effect in 2025, the report offers a dedicated analysis of its core impacts. This includes assessments of global and regional competitive dynamics, economic linkages, supply chain restructuring, and countries’ strategic responses. The report concludes with strategic recommendations and a forward-looking outlook for the Duchenne Muscular Dystrophy (DMD) Therapeutics market.
1. Key Global Players in the Duchenne Muscular Dystrophy (DMD) Therapeutics Industry:
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
2.Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmented by Product Type:
Exondys
Emflaza
Translarna
3. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Segmented by Application
Hospitals
Clinics
Home Care
4. Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, by Geographical Region:
North America (USA and Canada)
Europe (Germany, UK, France, Italy and other European countries)
Asia-Pacific (China, Japan, Korea, Taiwan, Southeast Asia, India, etc.)
Latin America (Mexico and Brazil, etc.)
Middle East and Africa (Turkey and Saudi Arabia, etc.)
I. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview:
1.1 Product Definition and Statistical Scope
1.2 On the basis of different product types, Duchenne Muscular Dystrophy (DMD) Therapeutics can be mainly categorized as follows:
Global Growth Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type 2020 VS 2024 VS 2031
Exondys
Emflaza
Translarna
1.3 From different applications, Duchenne Muscular Dystrophy (DMD) Therapeutics mainly includes the following:
Global Different Applications Duchenne Muscular Dystrophy (DMD) Therapeutics Growth Trend 2020 VS 2024 VS 2031
Hospitals
Clinics
Home Care
1.4 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Development Status and Future Trends (2020-2031)
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Growth Rate (2020-2031)
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Growth Rate (2020-2031)
II. Global Market Major Duchenne Muscular Dystrophy (DMD) Therapeutics Manufacturers Analysis:
2.1 Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Market Share
Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales (2020-2025)
Global Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share (2020-2025)
2.2 Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Market Share
Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue (2020-2025)
Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share (2020-2025)
Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Ranking by 2024
2.3 Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Price (2020-2025)
2.4 Global Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Headquarter and Origin Distribution
2.5 Global Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Establishment Date and Duchenne Muscular Dystrophy (DMD) Therapeutics Commercialization Date
2.6 Global Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Product Type and Application
2.7 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Concentration, Competition Analysis
Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Concentration Analysis: Global Top 5 Manufacturers Market Share by 2024
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics First Tier, Second Tier and Third Tier Manufacturers (Brand) and Market Share in 2024.
2.8 New Investments and Market M&A Activities
III. Profiles of the following key players:
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
1. Basic Information, Duchenne Muscular Dystrophy (DMD) Therapeutics Manufacturing Base, Headquarters, Competitors and Market Position.
2. Duchenne Muscular Dystrophy (DMD) Therapeutics Product Specifications, Parameters, and Market Applications .
3. Duchenne Muscular Dystrophy (DMD) Therapeutics Sales, Revenue, Price and Gross Margin in Global Market (2020-2025).
4. Company Profile and Key Businesses.
5. Latest Company News.
IV. Analysis of Different Product Types of Duchenne Muscular Dystrophy (DMD) Therapeutics:
4.1 Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales by Product Type (2020-2031)
Global Market Sales and Market Share of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type (2020-2025)
Global Market Sales Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Different Product Types (2026-2031)
4.2 Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Size by Product Type (2020-2031)
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Size and Market Share by Product Type (2020-2025)
Global Market Size Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type (2026-2031)
4.3 Global Market Price Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type (2020-2031)
V. Analysis of Duchenne Muscular Dystrophy (DMD) Therapeutics for Different Applications
5.1 Global Market Sales of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application (2020-2031)
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Market Share by Application (2020-2025)
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Forecast by Application (2026-2031)
5.2 Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Size and Market Share by Application (2020-2025)
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Size Forecast by Application (2026-2031)
5.3 Global Market Price Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application (2020-2031)
VI. Industry Development Environment Analysis
6.1 Development Analysis of Duchenne Muscular Dystrophy (DMD) Therapeutics Industry - Development Trend
6.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Development Analysis - Manufacturer Barriers
6.3 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Development Analysis - Driving Factors
6.4 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Development Analysis - Restraints
6.5 SWOT Analysis of Duchenne Muscular Dystrophy (DMD) Therapeutics Global Companies
6.6 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Development Analysis - Industry Policies
Industry Authorities and Regulatory Framework
Industry-related Policy Trends
Industry Related Planning
VII. Industry Supply Chain Analysis
7.1 Industry Chain Introduction of Duchenne Muscular Dystrophy (DMD) Therapeutics Industry
7.2 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Chain Analysis - Upstream
7.3 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Chain Analysis - Midstream
7.4 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Chain Analysis - Downstream
7.5 Procurement Mode of Duchenne Muscular Dystrophy (DMD) Therapeutics Industry
7.6 Production Mode of Duchenne Muscular Dystrophy (DMD) Therapeutics Industry
7.7 Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Sales Model and Sales Channels
VIII. Global Local Duchenne Muscular Dystrophy (DMD) Therapeutics Capacity, Production Analysis
8.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Supply and Demand Status and Forecast (2020-2031)
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Capacity, Production, Capacity Utilization and Development Trend (2020-2031)
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Production, Market Demand and Development Trend (2020-2031)
8.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Import and Export Analysis
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Main Import Sources
Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Main Export Destinations
IX. Research Findings and Conclusion
X. Appendix
10.1 Research Methodology
10.2 Data Sources
Secondary Information Sources
Primary Information Sources
10.3 Data Interactive Validation
10.4 Disclaimer”
Table of Contents
Table : Growth Trends in Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table:Growth Trend of Different Applications
Table:Current Development Status of Duchenne Muscular Dystrophy (DMD) Therapeutics Industry
Table:Development Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table:Global Major Regions Production of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table:Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Production Market Share
Table:Global Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Production Capacity
Table:Global Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales, Sales Market Share, Sales Revenue
Table:Global Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Revenue Market Share, Price
Table: Global Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Ranking by 2025
Table: China Market Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales, Sales Market Share, Sales Revenue
Table: China Market Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Revenue Market Share, Sales Price
Table: China Key Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Ranking by 2025
Table: Global Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Production Distribution and Commercialization Date
Table:Global Major Manufacturers Duchenne Muscular Dystrophy (DMD) Therapeutics Product Type List
Table: Global Key Manufacturers Market Position of Duchenne Muscular Dystrophy (DMD) Therapeutics in 2025 (First Tier, Second Tier and Third Tier)
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Analysis of Current Status of Investments, Mergers & Acquisitions, and Others
Table: Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Revenue
Table: Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Revenue Market Share
Table: Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share
Table: Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Volume
Table: Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share
Table : Global Major Regions Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Share
Table : The following companies:
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
Duchenne Muscular Dystrophy (DMD) Therapeutics Manufacturing Base, Sales Area, Competitors and Market Position
Duchenne Muscular Dystrophy (DMD) Therapeutics Product Specifications, Parameters and Market Applications
Duchenne Muscular Dystrophy (DMD) Therapeutics Sales, Revenue, Price and Gross Margin
Company Profile and Major Businesses
Latest Company News
Table: Global Sales of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Sales Market Share of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Sales Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Sales Market Share Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Revenue of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Product Type
Table: Global Revenue Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Revenue Market Share Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Price Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Table: Global Sales of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application
Table: Global Sales Market Share of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application
Table: Global Sales Forecast of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share Forecast by Application
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue by Application
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share by Application
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Forecast by Application
Table: Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share Forecast by Application
Table: Global Price Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application
Table: List of Duchenne Muscular Dystrophy (DMD) Therapeutics Upstream Raw Material Suppliers and Contact Information
Table: List of Typical Customers of Duchenne Muscular Dystrophy (DMD) Therapeutics
Table: Duchenne Muscular Dystrophy (DMD) Therapeutics Main Sales Modes and Sales Channels
Table: Development Opportunities and Key Driving Factors of Duchenne Muscular Dystrophy (DMD) Therapeutics Industry
Table: Risks Faced by Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Development
Table: Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Policy Analysis
Table: Research Scope
Table: List of Analysts
Chart Catalog
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Product Picture
Figure Global Production Market Share of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Consumption Market Share by Application
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Capacity, Production, Capacity Utilization and Development Trend
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Production, Demand and Development Trend
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Production Market Share by Major Regions
Figure China Duchenne Muscular Dystrophy (DMD) Therapeutics Capacity, Production, Capacity Utilization and Development Trend
Figure China Duchenne Muscular Dystrophy (DMD) Therapeutics Production, Market Demand and Development Trend
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Sales and Growth Rate.
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size
Figure Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Growth Rate
Figure Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Price Trend
Figure Global Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share of Major Manufacturers in 2025
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share of Key Manufacturers in Global Market in 2025
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Market Share of Key Manufacturers in China Market in 2025
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share of Key Manufacturers in China Market, 2025
Figure 2025 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Share of Top 5 Manufacturers
Figure 2025 Global Duchenne Muscular Dystrophy (DMD) Therapeutics First Tier, Second Tier and Third Tier Manufacturers (by Brand) and Market Share
Figure Global Duchenne Muscular Dystrophy (DMD) Therapeutics Sales Revenue Market Share by Major Regions
Figure North America Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Growth Rate
Figure North America Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Growth Rate
Figure Europe Market Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Growth Rate
Figure Europe Market Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Growth Rate
Figure China Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Growth Rate
Figure China Market Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Growth Rate
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Sales and Growth Rate in Japan Market
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue and Growth Rate in Japan Market
Figure Global Price Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Product Type
Figure Global Price Trend of Duchenne Muscular Dystrophy (DMD) Therapeutics by Application
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Industry Chain
Figure Duchenne Muscular Dystrophy (DMD) Therapeutics Chinese Companies SWOT Analysis
Figure Key Interview Objectives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
2025-04-19 11:11:59 
Pages: 99 
Tables: 122 
